Abbott India Limited vs Metro Brands Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Abbott India Limited (Pharmaceuticals) and Metro Brands Limited (Footwear and accessories retail) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Choose Abbott India Limited if you want exposure to India’s pharmaceutical sector, with the benefits of strong multinational parentage, established doctor and pharmacy relationships, and a focus on higher-margin branded formulations, while accepting risks linked to domestic market dependence, price controls, and a relatively concentrated therapy portfolio. Choose Metro Brands Limited if you prefer a play on Indian consumer growth via footwear and accessories, leveraging its broad brand portfolio, strong physical retail presence, and international partnerships, while recognizing its sensitivity to discretionary spending, premium positioning, and store-driven cost pressures. The right choice depends on whether your priorities lie more in healthcare-focused, branded pharma exposure or diversified discretionary retail consumption.
Grounded in the verified figures and SWOT shown — guidance, not investment advice.
Head-to-head highlights
| Metric | Abbott India Limited | Metro Brands Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | INR 5,800-6,200 crore | Around INR 2,300-2,400 crore | AI estimate |
| Net profit (approx.) | INR 1,100-1,300 crore | Around INR 400-450 crore | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
- Strong parentage from Abbott Laboratories
- Recognized brands in chronic and specialty therapeutic areas
- Established doctor and pharmacy distribution network
- Focus on higher-margin branded formulations
Weaknesses
- High dependence on the Indian domestic pharmaceutical market
- Limited scale compared with India's largest pharma companies
- Exposure to price controls on essential medicines
- Relatively concentrated portfolio in select therapies
Opportunities
- Growth in chronic disease treatment demand in India
- Expansion in women's health, gastroenterology, and metabolic care
- Digital engagement with physicians and patients
- Leveraging Abbott's global portfolio for India-specific launches
Threats
- Intense competition from Indian generic and branded-generic companies
- Regulatory pricing pressure from India's drug price control regime
- Changes in physician prescribing behavior
- Supply chain and input cost volatility
Metro Brands Limited
Footwear and accessories retail · India
Metro Brands Limited is an Indian footwear and accessories retailer operating through owned brands and select licensed or partner brands. Its portfolio spans fashion, casual, formal, and comfort footwear for men, women, and children across physical retail and online channels.
Verified financials
No source-verified financials available.
Strengths
- Established brand recognition in Indian footwear retail
- Diverse portfolio across price points and occasions
- Strong mall and high-street retail presence
- Partnership exposure to international brands such as Crocs
Weaknesses
- High dependence on discretionary consumer spending
- Retail-store operating costs can pressure margins
- Premium positioning may limit reach in price-sensitive markets
Opportunities
- Growth in organized footwear retail in India
- Expansion into smaller cities and omnichannel commerce
- Rising demand for casual, comfort, and athleisure footwear
- Additional international brand partnerships
Threats
- Intense competition from domestic and global footwear brands
- Discounting pressure from online marketplaces
- Raw material and supply-chain cost volatility
- Changing fashion trends and inventory risk
Frequently asked
Answered from source-verified figures on this page.
Abbott India Limited vs Metro Brands Limited: which company leads overall?
Abbott India Limited leads on Revenue (approx.) and Net profit (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
India Protein Industry Outlook — Intelligence Report
India Baby Food Market — Intelligence Report
Global Quick Commerce & Last-Mile Delivery Market — Intelligence Report
India Pharmaceutical Sector — Intelligence Report
AI Analyst
Insights and answers generated live from Abbott India Limited vs Metro Brands Limited's verified data. Modeled estimates — not investment advice.
- Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories.
- Abbott India markets branded prescription and over-the-counter healthcare products across gastroenterology, women’s health, metabolic disorders, central nervous system, pain management, and vaccines.
- Metro Brands Limited is an Indian footwear and accessories retailer operating through owned brands and select licensed or partner brands.
- Metro Brands sells fashion, casual, formal, and comfort footwear for men, women, and children across physical retail and online channels.
- Notable point: Abbott India operates in pharmaceuticals while Metro Brands is a footwear and accessories retailer, so the two companies are in clearly different consumer sectors.